A COVID-19 UPDATE: WHERE WE ARE AND WHERE WE NEED TO BE
Click here to view a write-up of this virtual event held on Thursday, November 5, 2020
In March 2020, The Jackson Laboratory (JAX) quickly mobilized its clinical laboratory to provide wide-scale COVID-19 testing capabilities for its employees and local communities.
Join JAX President and CEO, Edison Liu, M.D., who earned the President's Public Service Medal for leading Singapore's scientific response to the 2003 SARS crisis and Madeleine Braun, Ph.D., M.B.A., Chief of Presidential Initiatives, for a virtual discussion about the importance of COVID-19 testing, their learnings and the path forward for keeping our communities safe and healthy.
For questions, please contact us at firstname.lastname@example.org.
Edison T. Liu, M.D., President and CEO
Dr. Liu came to JAX after founding and leading the Genome Institute of Singapore. His scientific research focuses on the functional genomics of human cancers, investigating gene regulation on a genomic scale that modulates cancer biology. His laboratory investigates the expression signatures in breast cancers that define biochemical and genetic perturbations as well as the transcriptional regulation of estrogen receptors. Dr. Liu's work spans cancer biology, genomics, human genetics and molecular epidemiology.
Madeleine Braun, Ph.D., M.B.A., Chief of Presidential Initiatives
Madeleine Braun is the Chief of Presidential Initiatives leading The Jackson Laboratory's strategic institutional scientific initiatives. She previously served as Chief Information Officer; as Senior Director, Genotyping and Reproductive Sciences; and as Business Unit Manager for JAX Breeding Services. Prior to joining the Laboratory in 2007, Braun held Scientist positions at Seattle Genetics and Corixa Corporation. Braun holds a B.A. in biological sciences from Cornell University, a Ph.D. in genetics from the University of Washington, Seattle, and an MBA from the Yale School of Management.
Click here to view a write-up of the virtual event SCIENCE FOR THE COMMON GOOD: A DISCUSSION ON COVID-10 on May 26, 2020.
A virtual discussion about responding to a global pandemic, how a mouse model was developed to enable research into COVID-19, and how research will be utilized to study the disease for treatment in the future.